BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharmaconomics//FDA Catalyst Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:pharmaconomics-62@pharmaconomics
DTSTAMP:20260707T003556Z
DTSTART;VALUE=DATE:20260930
DTEND;VALUE=DATE:20261001
SUMMARY:DMTX Phase 3 — DISC-1459 (estimated date)
DESCRIPTION:Phase 3 trial results for DISC-1459 in Erythropoietic Protoporphyria (EPP) are due ~ Sep 30\, 2026. A clean hit validates the program\; a miss can gap the stock down hard.\n\nPrimary source: https://clinicaltrials.gov/study/NCT06910358\n\nTrack it: https://pharmaconomics.com/e/62
URL:https://pharmaconomics.com/e/62
TRANSP:TRANSPARENT
BEGIN:VALARM
TRIGGER:-P1D
ACTION:DISPLAY
DESCRIPTION:DMTX catalyst tomorrow
END:VALARM
END:VEVENT
END:VCALENDAR